A Study Of Acute Decompensated Heart Failure
HF-FOCUS: Serial Lung Ultrasound And Peripheral Venous Pressure Monitoring To Enhance The Care Of Hospitalized Patients With Acute Decompensated Heart Failure
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Mentioned in the study description
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Mentioned in the study description
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether daily HF-FOCUS exams can shorten hospital stays by 1 day and reduce repeat hospital stays for heart failure, compared with usual care. It is for adults in a heart care unit at St. Mary's Hospital whose heart failure has suddenly started or gotten worse.
The purpose of this study is to examine shorter hospitalization length as well as a reduced rates of recurrent heart failure hospitalization compared to current standard of care in Acute Decompensated Heart Failure. A 1-day reduction in hospital length of stay in unblinded subjects receiving daily HF-FOCUS examinations compared to a blinded standard of care arm.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- You are 18 or older.
- You are admitted to St. Mary's Hospital's Cardiology Progressive Care Unit under one of the Cardiology 1–5 teams.
- You were admitted for sudden or worsening heart failure that affects how the heart pumps or fills, or affects the right side of the heart; heart failure affecting both sides also qualifies.
- You can give informed consent, meaning you understand the study and agree to join.
- You are willing to have daily lung ultrasound exams, which use sound waves to make pictures, during your hospital stay.
Who can't join
- You are younger than 18.
- You cannot give informed consent to join the study.
- You are not willing to have daily lung ultrasound exams.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Subjects ≥18 years of age * Admitted to St. Mary's Hospital Cardiology Progressive Care Unit (Cardiology 1-5 teams) * Admission diagnosis of either: 1. Acute systolic heart failure 2. Acute on chronic systolic heart failure 3. Acute diastolic heart failure 4. Acute on chronic diastolic heart failure 5. Acute right heart failure 6. Acute on chronic right heart failure 7. Failure heart biventricular * Able to provide informed consent and willing to undergo daily lung ultrasound examinations during their hospitalization. Exclusion Criteria: * Subjects \<18 years of age * Unable to provide informed consent. * Unwilling to undergo daily lung ultrasound examinations.
Study sites (1)
MN
- Mayo Clinic in Rochester · Rochester, MN 55905Andy Dang · Study contact · 507-255-7752 · dang.phong@mayo.eduJared Bird, MD · Principal investigatorMore trials in Rochester